Simon Z. He - Publications

Antifungal prophylaxis in patients with FMS-like tyrosine kinase 3-internal tandem duplication (FLT3-ITD)-positive acute myeloid leukaemia receiving sorafenib during initial induction and consolidation treatment in ALLG AMLM16 trial.

Journal: The Journal of antimicrobial chemotherapy

Published: January 30, 2025

Efficacy and Long-Term Outcomes of Eltrombopag Treatment Within 6 Months of Diagnosis in Patients With Steroid Unresponsive or Dependent Immune Thrombocytopenia.

Journal: American journal of hematology

Published: September 17, 2024

Sorafenib plus intensive chemotherapy in newly diagnosed FLT3-ITD AML: a randomized, placebo-controlled study by the ALLG.

Journal: Blood

Published: March 28, 2023

Australasian Trends in Allogeneic Stem Cell Transplantation for Myelofibrosis in the Molecular Era: A Retrospective Analysis from the Australasian Bone Marrow Transplant Recipient Registry.

Journal: Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation

Published: July 02, 2020

Management of Patients With Erythropoietic Protoporphyria-Related Progressive Liver Disease.

Journal: Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society

Published: March 24, 2019

A Comparison of High-Dose Cytarabine During Induction Versus Consolidation Therapy in Newly Diagnosed AML.

Journal: HemaSphere

Published: June 01, 2018

Fulminant meningococcal sepsis due to non-groupable Neisseria meningitidis in a patient receiving eculizumab.

Journal: The Medical journal of Australia

Published: October 16, 2017

Suspected atypical haemolytic uraemic syndrome in two post-partum patients with foetal-death in utero responding to eculizumab.

Journal: Nephrology (Carlton, Vic.)

Published: February 09, 2017

Hyposplenic changes and pseudo-Pelger-Huët anomaly following allogeneic stem cell transplantation.

Journal: British journal of haematology

Published: October 11, 2016

A Phase 1 study of the safety, pharmacokinetics and anti-leukemic activity of the anti-CD123 monoclonal antibody CSL360 in relapsed, refractory or high-risk acute myeloid leukemia.

Journal: Leukemia & lymphoma

Published: September 25, 2014

Chronic neutrophilia associated with myeloma: is it clonal?

Journal: Leukemia & lymphoma

Published: May 30, 2013